STX
53
-4
LH
55
2
PLD
51
-5
ADT
33
5
UNP
48
-2
SYK
57
-2
BWA
42
-2
INTU
60
-3
CCL
71
4
SHW
71
-2
ICE
64
-5
HES
59
3
AN
49
2
NTAP
58
2
COST
51
-3
MNST
52
2
TAP
51
-2
KMI
59
2
TRIP
60
3
DVN
35
2
STX
53
-4
LH
55
2
PLD
51
-5
ADT
33
5
UNP
48
-2
SYK
57
-2
BWA
42
-2
INTU
60
-3
CCL
71
4
SHW
71
-2
ICE
64
-5
HES
59
3
AN
49
2
NTAP
58
2
COST
51
-3
MNST
52
2
TAP
51
-2
KMI
59
2
TRIP
60
3
DVN
35
2
Financhill
Back

ProShares UltraShort Nasdaq Biotech Stock Predictions

Hint at where the next big move in the market will be this month

Spot the next big move with this free book from a hedge fund manager
Sell
41

BIS
ProShares UltraShort Nasdaq Biotech

Last Price:
14.28
Seasonality Move:
-4.75%

7 Day Trial

ALL ACCESS PASS

$ 7

How this hedge fund manager trades weekly options

Claim your free training on trading weekly options

ProShares UltraShort Nasdaq Biotech Stock Forecast

  • Over the next 52 weeks, ProShares UltraShort Nasdaq Biotech has on average historically fallen by 28.3% based on the past 14 years of stock performance.
  • ProShares UltraShort Nasdaq Biotech has fallen lower in 11 of those 14 years over the subsequent 52-week period, corresponding to a historical accuracy of 78.57%
  • Is ProShares UltraShort Nasdaq Biotech Stock Undervalued?
    The current ProShares UltraShort Nasdaq Biotech [BIS] share price is $14.58. The Score for BIS is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • BIS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will ProShares UltraShort Nasdaq Biotech Stock Go Up Next Year?

  • Over the next 52 weeks, ProShares UltraShort Nasdaq Biotech has on average historically fallen by 28.3% based on the past 14 years of stock performance.

ProShares UltraShort Nasdaq Biotech Stock Rating

Sell
41
ProShares UltraShort Nasdaq Biotech (BIS) is a Sell

Is ProShares UltraShort Nasdaq Biotech overpriced?

  • ProShares UltraShort Nasdaq Biotech has fallen lower in 11 of those 14 years over the subsequent 52-week period, corresponding to a historical accuracy of 78.57%

ProShares UltraShort Nasdaq Biotech Stock Price History

Is BIS stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIS is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
26.51
52-Week Low:
14.07

Prediction Charts

Market Cap:
0
Price in USD:
14.58
Volume:
4.62K
Beta:
-1.69

Technical Analysis

SMA50:
14.98
SMA100:
16.25
SMA200:
17.40
52-Wk Change:
-33.08%

Stock Predictions

  • Is ProShares UltraShort Nasdaq Biotech stock public?
    Yes, ProShares UltraShort Nasdaq Biotech is a publicly traded company.
  • What is the ProShares UltraShort Nasdaq Biotech stock quote today?
    The ProShares UltraShort Nasdaq Biotech stock price is 14.58 USD today.
  • How to buy ProShares UltraShort Nasdaq Biotech stock online?
    You can buy ProShares UltraShort Nasdaq Biotech shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Aug-29 14.46 14.45 14.46 14.13
Aug-30 14.42 14.48 14.74 14.42
Sep-3 14.29 14.98 14.98 14.27
Sep-4 15.02 15.02 15.03 14.96
Sep-5 15.19 15.24 15.33 15.19
Sep-6 15.12 15.62 15.78 15.12
Sep-9 15.32 15.18 15.32 14.96
Sep-10 15.20 15.04 15.20 15.02
Sep-11 15.22 14.93 15.22 14.93
Sep-12 15.19 14.87 15.19 14.81
Sep-13 14.70 14.41 14.70 14.39
Sep-16 14.30 14.40 14.42 14.26
Sep-17 14.43 14.50 14.58 14.28
Sep-18 14.47 14.58 14.58 14.16

ProShares UltraShort Nasdaq Biotech Earnings

Data Unavailable

ProShares UltraShort Nasdaq Biotech Forecast Revenue Growth

Data Unavailable

* ProShares UltraShort Nasdaq Biotech stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.